Scala was founded by Ravit Netzer, Adi Goldenzweig in 2022.

Who are Scala's investors?

Scala's investors include Bullet Ventures, IT-Farm Corporation, TLV Partners, Deep Insight, Grove Ventures.

Scala

Founded 2022 · 34 employees on LinkedIn · 5 known investors

Find your way into Scala

Paths you didn't know you had: your email and LinkedIn already hold routes to the Scala team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Scala develops computational protein stability design technology that enables bacterial production of complex human enzymes, applied here to redesign human acetylcholinesterase (AChE) for high-yield, active expression in E. coli. The company's approach supports structural biology, enzyme engineering, and therapeutic and biodefense development in the biotechnology sector.

AI & Machine Learning Biotech Deep Tech

Founders & leadership

Scala was founded in 2022 by Ravit Netzer and Adi Goldenzweig.

Ravit Netzer Co-founder & CEORavit Netzer holds a Ph.D. in computational protein design from the Weizmann Institute of Science and brings over a decade of experience in protein engineering, including developing antibody design tools and methods for enhancing protein specificity and affinity. She is co-founder and CEO of Scala Bio, which develops computational protein stability design technology for bacterial production of complex enzymes.

Adi GoldenzweigCo-founder & CTOCo-founder & CTO at Scala Bio

Sarel Fleishman Chief ScientistSarel Fleishman is a professor at the Weizmann Institute of Science specializing in applied protein design, with expertise in antibody and enzyme engineering and methods for optimizing stability, expression, and activity in biologics.

Investors · 5

Bullet Ventureslisted by Bullet VenturesJerusalem

How we know: Bullet Ventures's portfolio page · Not right? Tell us

IT-Farm Corporationlisted by IT-Farm CorporationTokyovia Julien Nguyen · inferred

How we know: IT-Farm Corporation's portfolio page · Not right? Tell us

TLV Partnerslisted by TLV PartnersTel Aviv · $2M – $8M

How we know: TLV Partners's portfolio page · a partner's Signal profile · the VCSheet dataset · Not right? Tell us

Deep InsightreportedTel Aviv

How we know: open dataset · investor-profiles · Not right? Tell us

Grove VenturesreportedTel Aviv-Yafo

How we know: a partner's Signal profile · Not right? Tell us

Frequently asked questions

What does Scala do?: Scala develops computational protein stability design technology that enables bacterial production of complex human enzymes, applied here to redesign human acetylcholinesterase (AChE) for high-yield, active expression in E. coli. The company's approach supports structural biology, enzyme engineering, and therapeutic and biodefense development in the biotechnology sector.
Who founded Scala?: Scala was founded by Ravit Netzer, Adi Goldenzweig in 2022.
Who are Scala's investors?: Scala's investors include Bullet Ventures, IT-Farm Corporation, TLV Partners, Deep Insight, Grove Ventures.